Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06811038 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

iCanQuit Smoking Cessation Among Hispanic Adults

StatusNot Yet Recruiting
PhasePhase 3
Started2026-10-15
View on ClinicalTrials.gov ↗

Amendment history

2026-08-25
minor
Study Status v11
Start date2026-08-15→2026-09-15
2026-06-08
minor
Study Status v10
Start date2026-06-01→2026-08-15
2026-05-08
minor
Study Status v9
Start date2026-05-01→2026-06-01
2026-04-06
minor
Study Status v8
Start date2026-04-01→2026-05-01
2026-03-11
minor
Study Status v7
Start date2026-03-01→2026-04-01
Show 6 earlier versions
2026-01-06
minor
Study Status v6
Start date2026-01-01→2026-03-01
2025-11-10
minor
Study Status v5
Start date2025-11-01→2026-01-01
2025-08-08
minor
Study Status v4
Start date2025-08-01→2025-11-01
2025-07-07
minor
Study Status v3
Start date2025-07-01→2025-08-01
2025-06-03
minor
Study Status v2
Start date2025-06-01→2025-07-01
2025-02-18
minor
Study Identification, Study Status v1
Re-verified, no change to tracked fields
2025-01-31
minor
Original filing
This phase III trial compares a smartphone application with or without nicotine replacement therapy in improving smoking cessation among Hispanic adults who would like to quit smoking. The iCanQuit smartphone application focuses on skills for managing urges, motivation, and relapse prevention with personalized quit plans. Nicotine replacement therapy works by giving small, steady doses of nicotine to help stop cravings and relieve symptoms that occur when a person is trying to quit smoking without any of the other harmful chemicals found in tobacco products.
Trial Details
NCT Number NCT06811038
Lead Sponsor Fred Hutchinson Cancer Center
Collaborators: National Cancer Institute (NCI)
Conditions Cigarette Smoking-Related Carcinoma
Enrollment 854 participants
Start Date 2026-10-15
Primary Completion 2029-07-01 (estimated)
Study Completion 2030-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-09-21